Prognosys Biosciences, Inc. Release: University of California, San Diego (UCSD) uses RainDance Technologies’s Technology to Detect Rare Somatic Mutations in Solid Tumors Undetectable by Current Sequencing Methods

LEXINGTON, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., the Digital Biology™ Company, today announced the publication of data from a collaboration with the University of California, San Diego (UC San Diego) and Prognosys Biosciences that further validates RainDance’s “hotspot” approach for detecting low prevalence somatic mutations in heterogeneous tumor samples. The publication, entitled “Detection of Low Prevalence Somatic Mutations in Solid Tumors with Ultra-Deep Targeted Sequencing,” was published online by Genome Biology on December 20, 2011.